GHP Investment Advisors Inc. Has $2.43 Million Stock Position in CVS Health Co. (NYSE:CVS)

GHP Investment Advisors Inc. reduced its position in CVS Health Co. (NYSE:CVS) by 7.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 54,158 shares of the pharmacy operator’s stock after selling 4,537 shares during the period. GHP Investment Advisors Inc.’s holdings in CVS Health were worth $2,431,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Beacon Financial Advisory LLC raised its position in CVS Health by 4.4% during the fourth quarter. Beacon Financial Advisory LLC now owns 14,088 shares of the pharmacy operator’s stock valued at $632,000 after acquiring an additional 600 shares in the last quarter. Tectonic Advisors LLC increased its stake in shares of CVS Health by 12.6% during the 4th quarter. Tectonic Advisors LLC now owns 14,497 shares of the pharmacy operator’s stock worth $651,000 after purchasing an additional 1,619 shares during the last quarter. Lion Street Advisors LLC raised its holdings in shares of CVS Health by 18.3% during the 4th quarter. Lion Street Advisors LLC now owns 8,369 shares of the pharmacy operator’s stock valued at $376,000 after purchasing an additional 1,295 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in CVS Health by 25.1% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 132,645 shares of the pharmacy operator’s stock worth $5,884,000 after purchasing an additional 26,589 shares in the last quarter. Finally, Y.D. More Investments Ltd acquired a new position in CVS Health during the fourth quarter worth $144,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. Truist Financial decreased their price target on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a report on Tuesday, December 3rd. Mizuho decreased their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Finally, UBS Group raised their price target on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $68.12.

CVS Health Stock Down 2.7 %

Shares of CVS stock opened at $54.20 on Friday. The stock has a market cap of $68.21 billion, a P/E ratio of 13.76, a price-to-earnings-growth ratio of 0.62 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The stock has a fifty day moving average price of $51.02 and a 200 day moving average price of $56.04. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.21 earnings per share. Analysts predict that CVS Health Co. will post 5.14 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.91%. CVS Health’s payout ratio is presently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.